This year has brought a crisis that’s unlike anything the world has experienced before because it brought the world’s economy to a shuttering halt, but that doesn’t mean there haven’t been investment opportunities this year. Private equity, in particular, is turning out to be one of the big winners this year alongside technology, of course.
During CNBC’s Institutional Investor Delivering Alpha conference, H.E. Yasir Al-Rumayyan of Saudi Arabia’s sovereign wealth fund, Blackstone BX Chairman and CEO Stephen Schwarzman and Vista Equity Partners Chairman and CEO Robert Smith talked about strategies for achieving alpha with investments.
Even in challenging economic times, there are still winners and losers. Indeed, some companies are benefiting from the current circumstances, while others continue to trade under-the-investor-radar. However, it’s fair to say that it’s best to pick your stocks wisely in case further volatility lies ahead.
One way to go about this is to follow the latest stock recommendations from analysts with a proven track record of success. TipRanks analyst forecasting service attempts to pinpoint Wall Street’s best-performing analysts. These are the analysts with the highest success rate and average return measured on a one-year basis — factoring in
Tech gets hammered again as regulatory news hurts sector
Rotation from tech into other sectors appears to be losing steam
The air keeps coming out of the tires.
A market that rode hard all summer on the FAANGs and semiconductors is making a loud hissing noise as those high-flyers lose traction.
All summer, investors heard warnings that if Tech’s party settled down, the broader market would take a hit. September reminds us of that as it appears on track to be the first losing month since March and the worst month of September in 18 years.
All the FAANGs played serious defense Wednesday in the second of three sessions this week where Tech spent most of the day dragging everything else down. The Tech weakness was joined by a rout in the Energy sector, where companies staggered amid worries about shutdowns in Europe and
(Bloomberg) — Emerging-market stocks can’t catch a break.
Already a laggard in the global risk rally, they have just registered their longest losing sequence of daily declines since February as the selloff in U.S. technology shares adds to headwinds that include the rising tensions between Washington and Beijing in the run-up to the U.S. presidential election.
The MSCI Emerging Markets Index fell for the sixth consecutive day on Wednesday, dipping below a key support level — its 50-day moving average — for the first time since May. Investors got spooked by AstraZeneca Plc’s decision to pause its coronavirus vaccine trial and the Trump administration’s move to bar some companies based in China’s Xinjiang region.